Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Zydus_Cadila
|
| gptkbp:focusesOn |
rare diseases
specialty therapeutics |
| gptkbp:foundedYear |
2007
|
| gptkbp:headquartersLocation |
gptkb:Solana_Beach,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sentynl Therapeutics
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:parentCompany |
gptkb:Zydus_Lifesciences
|
| gptkbp:product |
Abstral
NULIBRY Sentynl Pain Portfolio |
| gptkbp:website |
https://www.sentynl.com/
|
| gptkbp:bfsParent |
gptkb:Levo-Dromoran
|
| gptkbp:bfsLayer |
8
|